3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
2
CNS
2
Breast
2
Thoracic
1
Plasma cell
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
874
Precursor Cell Lymphoblastic Leukemia-Lymphoma
499
Hematologic Neoplasms
462
Leukemia, Lymphocytic, Chronic, B-Cell
388
Leukemia
328
Myelodysplastic Syndromes
324
Lymphoma
203
Lymphoma, Non-Hodgkin
191
Multiple Myeloma
145
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
139
Recurrence
136
Neoplasms
133
Leukemia, Myelomonocytic, Chronic
110
Burkitt Lymphoma
92
Lymphoma, Mantle-Cell
91
Lymphoma, Follicular
91
Lymphoma, Large B-Cell, Diffuse
88
Myeloproliferative Disorders
84
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
81
Leukemia, Biphenotypic, Acute
79
Lymphoma, B-Cell, Marginal Zone
75
Hodgkin Disease
72
Lymphoma, B-Cell
64
Waldenstrom Macroglobulinemia
54
Primary Myelofibrosis
53
Leukemia, B-Cell
50
Anemia, Refractory, with Excess of Blasts
45
Leukemia, Myeloid, Chronic-Phase
40
Hematologic Diseases
37
Lymphoma, T-Cell
32
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Communication
×
Other hematologic neoplasm
×
1 year
×
Clear all
NCT05335369
2026-05-11
UR-GOAL 2
University of Rochester
Phase NA
Completed
161 enrolled
19 charts
NCT06102330
2025-08-03
HomeVENT
Johns Hopkins University
Phase NA
Recruiting
600 enrolled